BCAT Stock Forecast 2025-2026
Distance to BCAT Price Targets
BCAT Price Momentum
10 Quality Stocks Worth Considering Now
Researching BlackRock CAT (BCAT) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on BCAT and similar high-potential opportunities.
Latest BCAT Stock Price Targets & Analyst Predictions
BCAT has shown a year-to-date change of -4.6% and a 1-year change of -13.2%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for BCAT. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
BCAT Analyst Ratings
BCAT Price Target Range
Latest BCAT Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for BCAT.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
BlackRock Capital Allocation Trust (BCAT) Competitors
The following stocks are similar to BlackRock CAT based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
BlackRock Capital Allocation Trust (BCAT) Financial Data
BlackRock Capital Allocation Trust has a market capitalization of $1.53B with a P/E ratio of 7.9x. The company generates $197.67M in trailing twelve-month revenue with a 0.0% profit margin.
Revenue growth is N/A quarter-over-quarter, while maintaining an operating margin of 0.0% and return on equity of +11.3%.
Valuation Metrics
Growth & Margins
Financial Health
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
BlackRock Capital Allocation Trust (BCAT) Business Model
About BlackRock Capital Allocation Trust
Provides diversified investment solutions through a closed-end fund.
The Trust generates revenue by maintaining a diversified portfolio of equity and debt securities, focusing on sectors like technology, healthcare, and financial services. It aims to achieve current income, gains, and long-term capital appreciation through tactical asset allocation across various markets.
Managed by BlackRock, the Trust leverages extensive management expertise and research capabilities, appealing to investors seeking global exposure with an active management approach. It serves as a strategic option for balancing growth potential with income generation.
BlackRock Capital Allocation Trust (BCAT) Latest News & Analysis
CEF Weekly Review: Will BTT Terminate?
12 days agoIn early March, CEF sectors declined amid poor risk sentiment, though year-to-date performance is mostly positive, driven by EM assets. BlackRock Municipal 2030 Target Term renewed its share repurchase program.
The CEF market's downturn amid poor risk sentiment signals potential volatility, while positive year-to-date performance in EM assets and share repurchases by BlackRock may indicate future value opportunities.
BlackRock Capital Allocation Term Trust offers a 22.7% dividend yield but has seen a 4.3% price decline in the past year. It trades at a 4.6% discount to NAV and has a diverse portfolio.
BlackRock Capital Allocation Term Trust's high dividend yield and discounted price to NAV attract income-focused investors, despite recent price declines, indicating potential steady income despite capital limits.
BlackRock announced the renewal of discount management programs for its closed-end funds, allowing for potential share repurchases via tender offers under specific conditions.
The renewal of discount management programs indicates potential share repurchases, which can enhance shareholder value and may positively influence stock prices for $BCAT.
BlackRock announced multiple trusts including BCX, BDJ, BGR, BGY, BME, BMEZ, BOE, and BUI, focusing on resources, equity dividends, health sciences, and utilities.
The announcement of multiple BlackRock funds may signal new investment opportunities and strategies, impacting sector performance and investor sentiment in resources and dividends.
The CEF market showed strong performance in early February, with gains in EM Equity and Muni sectors. Preferred CEFs outperformed ETFs last year, with positive year-to-date NAVs and discounts.
Strong performance in the CEF market, particularly in EM Equity and Muni sectors, signals positive investor sentiment and potential opportunities, especially in preferred CEFs outperforming ETFs.
BCAT's 20% managed distribution policy has helped narrow its discount, though recent market volatility has caused a share price drop and wider discount, potentially making it attractive to investors.
BCAT's 20% distribution yield and discount management may attract investors seeking income, despite recent volatility and Saba's reduced stake, highlighting potential value amid changing market conditions.
Frequently Asked Questions About BCAT Stock
What is BlackRock Capital Allocation Trust's (BCAT) stock forecast for 2025?
Analyst forecasts for BlackRock Capital Allocation Trust (BCAT) are not currently available. The stock is trading at $14.46.
Is BCAT stock a good investment in 2025?
Analyst ratings for BCAT are not currently available. The stock is currently trading at $14.46. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for BCAT stock?
Price predictions from Wall Street analysts for BCAT are not currently available. The stock is trading at $14.46.
What is BlackRock Capital Allocation Trust's business model?
The Trust generates revenue by maintaining a diversified portfolio of equity and debt securities, focusing on sectors like technology, healthcare, and financial services. It aims to achieve current income, gains, and long-term capital appreciation through tactical asset allocation across various markets.
What is the highest forecasted price for BCAT BlackRock Capital Allocation Trust?
Price targets from Wall Street analysts for BCAT are not currently available. The stock is trading at $14.46.
What is the lowest forecasted price for BCAT BlackRock Capital Allocation Trust?
Price targets from Wall Street analysts for BCAT are not currently available. The stock is trading at $14.46.
What is the overall BCAT consensus from analysts for BlackRock Capital Allocation Trust?
Analyst ratings for BCAT are not currently available. The stock is trading at $14.46.
How accurate are BCAT stock price projections?
Stock price projections, including those for BlackRock Capital Allocation Trust, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
